Half the world population could be diabetic or insulin resistant by 2050
(fortune.com)
Half the world population could be diabetic or insulin resistant by 2050
Half the world population could be diabetic or insulin resistant by 2050
Continuous glucose monitors reveal variable glucose responses to the same meals
(examine.com)
Continuous glucose monitors reveal variable glucose responses to the same meals
Continuous glucose monitors reveal variable glucose responses to the same meals
Scientists May Have Found a Natural Alternative to Ozempic
(sciencealert.com)
Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to drugs like Ozempic.
Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to drugs like Ozempic.
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar
(nytimes.com)
A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.
A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.
Low-carb diets work. Why does American Diabetes Assoc. push insulin? (2024)
(theguardian.com)
For a glimpse into how big business influences the $4tn US healthcare system, look no further than the world’s most powerful diabetes advocacy and research non-profit, the American Diabetes Association (ADA).
For a glimpse into how big business influences the $4tn US healthcare system, look no further than the world’s most powerful diabetes advocacy and research non-profit, the American Diabetes Association (ADA).
Alzheimer's Disease as Type 3 Diabetes
(gethealthspan.com)
Over the past several decades, Alzheimer’s disease (AD) has been predominantly explained through the lens of amyloid-beta plaques and neurofibrillary tangles, yet an emerging paradigm shift increasingly recognizes metabolic dysfunction—specifically, insulin resistance—as a key driver of AD.
Over the past several decades, Alzheimer’s disease (AD) has been predominantly explained through the lens of amyloid-beta plaques and neurofibrillary tangles, yet an emerging paradigm shift increasingly recognizes metabolic dysfunction—specifically, insulin resistance—as a key driver of AD.
Small, Light, Robust Phones for a Type 1 Diabetic Child
(geek.nz)
Our 4yo T1D son, Sam, needs to carry a phone everywhere he goes to act as his pancreas.
Our 4yo T1D son, Sam, needs to carry a phone everywhere he goes to act as his pancreas.
Building a T1D smartwatch for my son from scratch
(andrewchilds.com)
My 9 y.o. son has Type 1 diabetes, which basically means his pancreas is on manual (hard) mode 24x7.
My 9 y.o. son has Type 1 diabetes, which basically means his pancreas is on manual (hard) mode 24x7.
Weight-loss jabs linked to reduced risk of 42 conditions including dementia
(theguardian.com)
People with diabetes taking medications found in weight-loss jabs have a reduced risk of 42 conditions, research has found, paving the way for such drugs being used to treat a host of health problems.
People with diabetes taking medications found in weight-loss jabs have a reduced risk of 42 conditions, research has found, paving the way for such drugs being used to treat a host of health problems.
Study links sugar-filled drinks to millions of heart disease and diabetes cases
(bgr.com)
From sodas to energy drinks, the consumption of sugary drinks has been linked to more than 2.2 million new cases of diabetes and 1.1 million new cases of heart disease annually, raising concerns over the health risks these drinks bring to the table.
From sodas to energy drinks, the consumption of sugary drinks has been linked to more than 2.2 million new cases of diabetes and 1.1 million new cases of heart disease annually, raising concerns over the health risks these drinks bring to the table.
Type 2 Diabetes and cardiovascular disease attributable to sugar beverages
(nature.com)
The consumption of sugar-sweetened beverages (SSBs) is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). However, an updated and comprehensive assessment of the global burden attributable to SSBs remains scarce.
The consumption of sugar-sweetened beverages (SSBs) is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). However, an updated and comprehensive assessment of the global burden attributable to SSBs remains scarce.
Researchers design wearable tech that can sense glucose levels more accurately
(uwaterloo.ca)
Waterloo researchers design wearable tech that can sense glucose levels for diabetics more accurately than ever before
Waterloo researchers design wearable tech that can sense glucose levels for diabetics more accurately than ever before
The case for clinical trial abundance
(ifp.org)
In 2014, the first SGLT2 inhibitor, dapagliflozin, was approved for patients with Type II diabetes for the control of blood glucose levels. Since then, the list of indications for this class of molecules has expanded to include kidney disease (2021) and heart failure (2020) in non-diabetics, both important sources of morbidity and mortality. Despite being an already developed drug with safety data, these repurposings took seven and six years, respectively.
In 2014, the first SGLT2 inhibitor, dapagliflozin, was approved for patients with Type II diabetes for the control of blood glucose levels. Since then, the list of indications for this class of molecules has expanded to include kidney disease (2021) and heart failure (2020) in non-diabetics, both important sources of morbidity and mortality. Despite being an already developed drug with safety data, these repurposings took seven and six years, respectively.
What is metformin's secret sauce?
(news.northwestern.edu)
A new Northwestern Medicine study has provided direct evidence in mice that the drug reversibly cuts the cell’s energy supply by interfering with mitochondria, often referred to as the cell’s “powerhouse,” to lower glucose levels.
A new Northwestern Medicine study has provided direct evidence in mice that the drug reversibly cuts the cell’s energy supply by interfering with mitochondria, often referred to as the cell’s “powerhouse,” to lower glucose levels.
Ozempic increases risk of debilitating eye condition: studies
(sdu.dk)
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye, which can lead to severe and permanent loss of vision.
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye, which can lead to severe and permanent loss of vision.
Chocolate intake and risk of type 2 diabetes: prospective cohort studies
(bmj.com)
The global prevalence of type 2 diabetes (T2D) has increased noticeably over the past few decades, with an estimated 463 million people affected worldwide in 2019 and projected to increase to 700 million by 2045.
The global prevalence of type 2 diabetes (T2D) has increased noticeably over the past few decades, with an estimated 463 million people affected worldwide in 2019 and projected to increase to 700 million by 2045.
Ozempic Could Prevent Diabetes. Should It Be Used for That?
(nytimes.com)
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a use for the drugs.
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a use for the drugs.
Show HN: The App I Built to Help Manage My Diabetes
(apple.com)
Take control of your health with Islet, the ultimate personalized health journal app designed to seamlessly track and analyze your glucose levels.
Take control of your health with Islet, the ultimate personalized health journal app designed to seamlessly track and analyze your glucose levels.
A new stronger Ozempic is coming. Here's what to know
(qz.com)
Novo Nordisk (NVO-4.34%) teased some new details about a potential Ozempic successor during a call with investors Tuesday.
Novo Nordisk (NVO-4.34%) teased some new details about a potential Ozempic successor during a call with investors Tuesday.
Study reveals blood sugar control is a key factor in slowing brain aging
(bgu.ac.il)
A new international study, led by Ben-Gurion University of the Negev as part of the DIRECT PLUS Brain MRI trial, has brought to light how blood sugar control can significantly impact brain health.
A new international study, led by Ben-Gurion University of the Negev as part of the DIRECT PLUS Brain MRI trial, has brought to light how blood sugar control can significantly impact brain health.
Diabetes risk soars for adults who had a sweet tooth as kids
(nature.com)
It’s tough news to hear on Halloween: a sugary diet in the first two years of life is linked to a higher risk of diabetes and high blood pressure decades later, according to an analysis of UK sugar rationing in the 1950s.
It’s tough news to hear on Halloween: a sugary diet in the first two years of life is linked to a higher risk of diabetes and high blood pressure decades later, according to an analysis of UK sugar rationing in the 1950s.
Sugar Rationing Lowered Diabetes and Hypertension in British Children
(nytimes.com)
People who were restricted to limited amounts of sugar in the first few years of life were less likely to develop diabetes and high blood pressure decades later, a new study has found.
People who were restricted to limited amounts of sugar in the first few years of life were less likely to develop diabetes and high blood pressure decades later, a new study has found.
'Smart' insulin prevents diabetic highs – and deadly lows
(nature.com)
Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in the blood. In animals, this ‘smart’ insulin1 reduced high blood-sugar concentrations effectively while preventing levels from dropping too low.
Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in the blood. In animals, this ‘smart’ insulin1 reduced high blood-sugar concentrations effectively while preventing levels from dropping too low.
Covid-19 linked to type 2 diabetes onset in children
(medicalxpress.com)
Pediatric patients aged 10 to 19 years old diagnosed with COVID-19 have a higher risk of new-onset type 2 diabetes within six months compared to those diagnosed with other respiratory infections, according to researchers at Case Western Reserve University School of Medicine.
Pediatric patients aged 10 to 19 years old diagnosed with COVID-19 have a higher risk of new-onset type 2 diabetes within six months compared to those diagnosed with other respiratory infections, according to researchers at Case Western Reserve University School of Medicine.
Stem cells reverse woman’s diabetes
(nature.com)
A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells1.
A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells1.
Study links bananas, oats and yoghurt to greater diabetes risk in susceptible
(theguardian.com)
Children who are susceptible to type 1 diabetes and eat bananas, oats and yoghurt are more likely to contract the disease, while consuming strawberries and blueberries lowers the risk, research has found.
Children who are susceptible to type 1 diabetes and eat bananas, oats and yoghurt are more likely to contract the disease, while consuming strawberries and blueberries lowers the risk, research has found.